Healthline6d
How to Mentally Recover from a Severe COPD Attack
During and after an exacerbation, mental recovery involves taking care of both your physical and mental health. Resting, ...
Apogee Therapeutics Announces First Patient Dosed in Part B of Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis
Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolled Part A 16-week proof-of-concept data anticipated in mid-2025 SAN FRANCISCO and BOSTON, Feb.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...
Medscape7d
High Dose N--Acetylcysteine in Patients With Exacerbations of Chronic Obstructive Pulmonary Disease
Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).
Pharm Exec24d
Novo Holdings Invests in Windward Bio
In the same press release, Novo Holdings senior partner Naveed Siddiq added, “Addressing the unmet needs of patients with severe, uncontrolled asthma and COPD ... to provide effective treatment ...
Finanznachrichten26d
Novo Holdings invests in $200M Series A for Windward Bio launch to advance long-acting treatments for asthma and COPD
Additional clinical trials are planned in asthma and chronic obstructive pulmonary disease (COPD ... with a dosing regimen of every six months, which can reduce the burden of treatment and ...
Oral Syringes Industry Eyes $1.05 Billion Opportunity by 2030: Baxter, BD, Medtronic, Terumo Medical Corp, and Braun Lead the Competition
The Clear Oral Syringes Segment Held the Largest Share in 2024, Accounting for 62.9% of Total Revenues Oral Syringes Market Oral Syringes Market Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "Oral ...
Enumclaw Courier-Herald7d
Breathe Drops for Respiratory Relief Exposed: The Truth About Its Benefits for COPD and Asthma
In a world where respiratory issues are increasingly common, finding practical solutions can be daunting. Breathe Drops ...
expresshealthcare7d
Leveraging AI for predictive analytics in chronic disease management
Subhro Mallik highlights the transformative role of AI and predictive analytics in chronic disease management, offering early ...
pharmaphorum3d
Study finds AZ's benralizumab a 'game-changer' in asthma
Nearly four million patients with asthma or chronic obstructive pulmonary disease (COPD ... dosing regimens given with placebo. The group taking prednisolone alone had a 74% treatment failure ...
Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board
Dr. Wimms brings two decades of sleep medicine industry and research expertise to her advisory role at Incannex. Dr. Wimms holds a Doctor of Philosophy (Ph.D.) in Medicine, and Master of Medicine ...
Pharmabiz1d
Apogee begins patient dosing in Part B of phase 2 APEX trial of APG777 to treat moderate-to-severe atopic dermatitis
Apogee begins patient dosing in Part B of phase 2 APEX trial of APG777 to treat moderate-to-severe atopic dermatitis: San Francisco Tuesday, February 4, 2025, 18:00 Hrs [IST] Apog ...